IP Library Granted Patent US 8,187,879
Granted Patent B2
US 8,187,879 · App. 12/279,853 · Granted May 29, 2012

Collection and selection methods to isolate a stem cell population from human adult periodontal follicular tissues

Assignee: Teslab S.R.L.
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 8,187,879
App. No.
12/279,853
Granted
May 29, 2012
Kind
B2
Abstract

Methods for the isolation, expansion and storage of a population of stem cells belonging to human dental follicles, called FENC (Follicle-derived Embryonic Neural Crest stem cells,) including: a) Collection of the follicular sack in sterile conditions, digestion and primary culture growth and expansion; b) Optional amplification; c) FACsorting.

Claims (13)

1. A method for the isolation of a population of stem cells from human dental follicles comprising:

a) collecting intact human dental follicular sacks;

b) digesting the follicular sacks in sterile conditions to produce a digestive solution;

c) filtering and then centrifuging the digestive solution to produce a cellular suspension;

d) isolating the cellular suspension;

e) culturing the cellular suspension in a culture media specific for stem cells to produce a primary culture;

f) optionally allowing the cells in the primary culture to amplify;

g) isolating stem cells by FACsorting using antibodies against SSEA-4, TRA 1-60, TRA1-81, CD133, CD90, flk-1, and OCT-4.

2. The method according to claim 1 , in which the digestion is carried out using proteolytic enzymes and antibiotics.

3. The method according to claim 2 , in which the enzymatic digestion is carried out by means of an aqueous solution containing: 3 mg/mL type I collagenase, 4 mg/mL dispase, 100 U/mL penicillin, 100 μg/mL streptomycin, 500 μg/mL clarytromicin in PBS.

4. The method according to claim 3 , in which the enzymatic digestion is carried out for 1 hour at 37° C., under shaking.

5. The method according to claim 1 , in which the culture media is supplemented with 10% p/v FBS, 100 μM 2P-ascorbic acid, 2 mM L-glutamine, 100 U/mL penicillin, 100 μg/mL streptomycin.

6. The method according to claim 5 , in which the incubation is carried out at 37° C. and in an atmosphere of 5% CO 2 for 15-20 days, changing the medium every 3 days.

Assignments (2)
MERGER Recorded Oct 31, 2023
From: TESLAB S.R.L.
To: POLO TECNOLOGICO PIEMONTESE SRL
Reel/Frame 065399/0137 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Dec 12, 2008
From: LAINO, GREGORIO; PAPACCIO, GIANPAOLO; DE ROSA, ALFREDO; D'AQUINO, RICCARDO; GRAZIANO, ANTONIO
To: TESLAB S.R.L.
Reel/Frame 021970/0068 →
Priority Claims (1)
IT NA2006A0017 · Feb 20, 2006 · national
Continuity (1)
Related Publication 20090291065A1 · Nov 26, 2009